MDNAF — Medicenna Therapeutics Corp.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1807983 ·
Ontario, Canada
Last close
$0.32
Market Cap
$29.17M
52W High
$1.43
52W Low
$0.23
ADV30
43,407
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -5,451,000 | -5,082,000 | 8,249,000 | 5,691,000 | 6,576,000 |
| Mar 2026 | 0 | — | -5,822,000 | -4,234,000 | 8,454,000 | 6,251,000 | 5,972,000 |
| Dec 2025 | 0 | — | -5,616,000 | -4,364,000 | 13,065,000 | 10,614,000 | 6,853,000 |
| Sep 2025 | 0 | — | -5,470,000 | -4,883,000 | 18,041,000 | 15,748,000 | 7,799,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-17,923,000
Investing CF
$2,000
Financing CF
$-19,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-136,661,000
Inventory
—
Receivables
$1,346,000
ST Investments
—
EBIT TTM
$-22,417,000
Pretax Income TTM
$-18,409,000
Interest Exp TTM
—
Analysts
2
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -22,417,000 | -18,409,000 | 8,454,000 | 5,972,000 | 2,482,000 | -17,923,000 |
| Mar 2025 | 0 | -20,406,000 | -11,805,000 | 28,382,000 | 9,287,000 | 19,095,000 | -16,492,000 |
| Mar 2024 | 0 | -18,674,000 | -25,466,000 | 19,134,000 | 13,943,000 | 5,191,000 | -16,260,000 |
| Mar 2023 | 0 | -16,303,000 | -10,048,000 | 36,446,000 | 6,960,000 | 29,486,000 | -12,657,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IGC | IGC Pharma, Inc. | $28.94M | $0.28 | — |
| RDPTF | Radiopharm Theranostics Ltd | $28.89M | $0.01 | — |
| RLFTY | MindMaze Therapeutics Holding SA | $28.51M | $0.17 | — |
| CNTX | Context Therapeutics Inc. | $27.95M | $0.30 | — |
| MCRB | Seres Therapeutics, Inc. | $27.22M | $2.71 | — |
News headlines (Yahoo Finance, 1h cache)
Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026
2026-10-05 13:00 · Yahoo
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
2026-10-01 23:00 · Yahoo
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
2026-09-24 11:00 · Yahoo
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-03 11:00 · Yahoo
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
2026-08-14 11:00 · Yahoo
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
2026-06-26 12:45 · Yahoo
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
2026-06-11 11:00 · Yahoo
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
2026-06-03 11:00 · Yahoo
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
2026-05-28 13:10 · Yahoo
Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
2026-05-22 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.